| Literature DB >> 27096320 |
Chunyan Zhang1, Hong Xin1, Wang Zhang1, Paul J Yazaki2, Zhifang Zhang2, Keith Le2, Wenzhao Li1, Heehyoung Lee1, Larry Kwak3, Stephen Forman3, Richard Jove4, Hua Yu1,5.
Abstract
The participation of a specific subset of B cells and how they are regulated in cancer is unclear. Here, we demonstrate that the proportion of CD5(+) relative to interleukin-6 receptor α (IL-6Rα)-expressing B cells was greatly increased in tumors. CD5(+) B cells responded to IL-6 in the absence of IL-6Rα. IL-6 directly bound to CD5, leading to activation of the transcription factor STAT3 via gp130 and its downstream kinase JAK2. STAT3 upregulated CD5 expression, thereby forming a feed-forward loop in the B cells. In mouse tumor models, CD5(+) but not CD5(-) B cells promoted tumor growth. CD5(+) B cells also showed activation of STAT3 in multiple types of human tumor tissues. Thus, our findings demonstrate a critical role of CD5(+) B cells in promoting cancer.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27096320 PMCID: PMC4844010 DOI: 10.1016/j.immuni.2016.04.003
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745